title: [Clinical evaluation of sulbactam/cefoperazone in obstetric and gynecological infection].
abstract: Sulbactam (SBT)/cefoperazone (CPZ) is the combined drug of SBT (beta-lactamase inhibitor) and CPZ by 1 to 1 to get spectrum covering much wider range than CPZ only. SBT/CPZ was used in 6 cases of female intrauterine and intrapelvic infections and 3 cases of external genital infections. The clinical efficiency was almost good excluding adnexitis. There were neither subjective and objective side effects nor abnormal laboratory findings.
mesh_terms: D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D002438:Cefoperazone / Q000008:administration & dosage* / Q000009:adverse effects; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D007263:Infusions, Parenteral; D008875:Middle Aged; D010397:Penicillanic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D013407:Sulbactam; D065093:beta-Lactamase Inhibitors
chemical_list: D004338:Drug Combinations; D065093:beta-Lactamase Inhibitors; D002438:Cefoperazone; D010397:Penicillanic Acid; D013407:Sulbactam